1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
Global Needle-Free Diabetes Management Market Size, Share, Development, Growth and Demand Forecast to 2025  Industry Insights by Device Type

Global Needle-Free Diabetes Management Market Size, Share, Development, Growth and Demand Forecast to 2025 Industry Insights by Device Type

  • February 2017
  • 101 pages
  • ID: 4713789
  • Format: PDF
  • By Prescient & Strategic Intelligence Private Limited

Summary

Table of Contents

Market Overview
Needle-free diabetes management refers to treatment, diagnosis and monitoring of diabetic patients without using needles. Needle-free diabetes management devices are used for injecting insulin and monitoring blood glucose level in diabetic patients. Controlling blood glucose levels in diabetes requires administration of insulin in human body, which is conventionally done by injecting insulin with needles. Parenteral dosage forms are intended for administration, as an injection or infusion. Parenteral administration of drug is one of the most widespread methods of drug delivery.

Insulin in delivered with the help of various delivery devices, such as insulin pumps, pen injectors, insulin syringe and jet injectors. Insulin syringes are most commonly used delivery system for self-medication. However, insulin syringe not being convenient option for few, has resulted in development of other devices for the treatment of diabetes.

The key problems associated with parenteral drug delivery are lack of safety, sterility, affordability, accuracy and convenience. Conventional insulin delivery devices have several draw backs such as high cost, chances of needle-stick injuries, and possible infections. These factors lead to increased demand for needle-free diabetes management. Needle-free diabetes management devices are easy and secure to use. These devices are novel systems to introduce insulin into patients without piercing the skin with a needle. Needle-free diabetes treatment devices propel insulin at high speed, which penetrates the skin for intradermal, subcutaneous, or intramuscular administration.

Needle-free diabetes management devices are mainly of three types, including treatment devices, diagnostic devices and artificial pancreas. The treatment devices are used to administer or infuse insulin in diabetic patients, whereas diagnostic devices are used to monitor blood glucose levels without needle. Artificial pancreas is developed for the automatic monitoring of blood sugar levels by functioning similarly as healthy pancreas.



Needle Free Diabetes Management Market

Market Dynamics
The global needle-free diabetes management market is expected to witness a CAGR of 17.8% during the forecast period, to reach $16,831.5 million by 2025. The increasing awareness regarding the safety issues associated with needles is the key growth driver for the global market. Among the different types of needle-free diabetes management devices, artificial pancreas market is expected to witness the fastest growth during the forecast period.

Opportunity

The adoption of needle-free diabetes management in the emerging economies is expected to provide huge growth potential for the market, during the forthcoming years. The growth will be driven by the increasing healthcare awareness, increasing healthcare spending, and regulatory initiatives for needle stick injuries. Although the market is growing at a significant rate in the emerging economies, especially in Asia-Pacific and Latin America, there is still massive unexplored market for needle-free diabetes management devices. With the boom in e-commerce industry in Asia, the major manufacturers of the needle-free diabetes management devices are penetrating the untapped market in the region.

Growth Drivers

The factors driving the growth of the needle-free diabetes management market are growing geriatric population, increasing prevalence of diabetes and technological advancements. The development of technologically advanced diabetes management devices has become necessary to ensure increased healthcare efficiency and productivity. Earlier, diabetic patients needed to prick their fingers to obtain blood sample for frequent glucose level monitoring. However, with the development of advanced biosensors, glucose monitoring has become easy to operate and painless. Also, these devices are designed for use in at home, so patients are capable of monitoring blood glucose level frequently. Similarly, treatment of diabetes has also become needle-free with the development of advanced insulin jet injectors. These devices help patient to painlessly inject drugs themselves, while eliminating the risk of infection and needle-stick injuries associated with the use of insulin delivery through needle.

Competitive Landscape
The global needle-free diabetes management device manufacturers are focusing on the product innovation to strengthen their position in the global market. Some of the key players in the global market include Medtronic plc, Insulet Corporation, Tandem Diabetes Care, Inc., Inovio Pharmaceuticals, Inc., Pharmajet, Inc., Zogenix, Inc., Antares Pharma Inc., and Glide Pharmaceutical Technologies Ltd.

Scope for Customization
P&S Market Research offers customization as per specific business requirements of clients. Illustrative customization within the scope of this report includes:

Period of Analysis – Increase in the study period, including historic and forecast years
Geographical Analysis – Increase in country coverage
Segment Analysis – More granular coverage related to:
Country level market breakdown by device type
Company Profiles – Wider company coverage in terms of detailed analysis or additional company profiles
New custom report – A completely customized report can be provided on the market, specific to a region/ country/ segment

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Global Autoinjectors Industry

Global Autoinjectors Industry

  • $ 4950
  • February 2020

Autoinjectors market worldwide is projected to grow by US$89.1 Billion, driven by a compounded growth of 22.7%. Rheumatoid Arthritis, one of the segments analyzed and sized in this study, displays the ...

NAD Dependent Protein Deacetylase Sirtuin 1 - Pipeline Review, H1 2020

NAD Dependent Protein Deacetylase Sirtuin 1 - Pipeline Review, H1 2020

  • $ 3500
  • January 2020

NAD Dependent Protein Deacetylase Sirtuin 1 - Pipeline Review, H1 2020SummaryNAD Dependent Protein Deacetylase Sirtuin 1 (SIR2 Like Protein 1 or Sirtuin Type 1 or Regulatory Protein SIR2 Homolog 1 or SIRT1 ...

Prefilled Syringes Market (5th Edition), 2020-2030

Prefilled Syringes Market (5th Edition), 2020-2030

  • $ 4899
  • January 2020

INTRODUCTIONAccording to experts in the healthcare industry, one in three adults are estimated to be suffering from some type of chronic clinical condition, such as multiple sclerosis, diabetes, rheumatoid ...


Download Unlimited Documents from Trusted Public Sources

Therapy Market in the US

  • February 2020
    101 pages
  • Therapy  

    Cystic Fibrosis  

    Hospital  

  • United States  

View report >

Antidiabetics Market in India

  • February 2020
    2 pages
  • Antidiabetics  

    Cardiology  

    Pharmaceutical  

  • India  

    Asia  

View report >

Antimalarials and Antidiabetics Market

  • February 2020
    137 pages
  • Antimalarials  

    Antidiabetics  

    Sodium-Glucose ...  

  • Australia  

    United States  

    North America  

View report >

ref:plp2017

Reportlinker.com © Copyright 2020. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on